US Regulator Seeks to Drop 5 Million Penalty Against Winklevoss Gemini Exchange Puerto Rico Tourism Sector Shows Potential for Growth in 2026 as Travelers Seek Unique Destinations Indias Finance Minister Signals Openness to Address Investor Tax Concerns on Capital Gains Safety Risks in Aramcos Supply Chain Raise Concerns for World Cup Sponsor Report Finds Byju Raveendran Sentenced to Jail by Singapore Court for Contempt General Dynamics Outlook Raised by SP on Strong Credit Metrics GAINI Q1 2026 Earnings EPS Misses Estimates Notes Decline Slightly Visa Q1 2026 Earnings EPS Beats Estimates by 482 as Payments Volume Remains Resilient QTTB Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Pipeline Progress GHC Q1 2026 Earnings EPS Surges Past Estimates by 268 MLAB Q1 2026 Earnings Earnings Per Share Surges Past Estimates by Over 130 SFB Q1 2026 Earnings Slight EPS Beat on Core Operations Hut 8 HUT Holds Near 1059 as Bitcoin Mining Stock Shows Modest Gains SiriusPoint SPNT Edges Lower as Stock Holds Above Key Support Zone KKR Income Opportunities Fund KIO Edges Higher on Steady Demand for Income Assets Spectrum Brands Holdings SPB Surges Over 37 as Bulls Test Key Resistance Zone Darden Restaurants DRI Holds Steady Near 205 as Mixed Signals Keep Traders Cautious Spotify Surges After AI Music Deal with Universal Music Group and Investor Day Guidance AWK Q1 2026 Earnings EPS Misses Estimates but Stock Edges Higher on Regulatory Strength QuantumSi QSI Edges Higher Modest Gain Amid Consolidation Near Support GeneDx Holdings Warrants Rally 1477 From Penny Level Yet Resistance Remains Stubborn Mountain Lake Acquisition Corp MLAC Holds Steady Near 1060 Amid Tight Trading Range Heartbeam Inc Warrant BEATW Surges 1077 as Trading Intensifies Near Key Level AvalonBay Communities AVB Edges Higher as Apartment Demand Remains Sturdy LVS Hovers Near Flat with Cautious Trading as Key Levels Remain in Focus Jefferies Financial Group JEF Holds Steady Near 5256 as Support and Resistance Define Trading Range Chemomab Therapeutics CMMB Stages a Sharp Rebound Can the Biotech Sustain Its Upward Momentum